Expert Opinion Statement on Continuous Glucose Monitoring in Type 2 Diabetes in the Arab Gulf Region.

The introduction of continuous glucose monitoring (CGM) has been considered a transformative monitoring tool in diabetes management. However, its adoption remains limited in the Gulf region, especially for patients with type 2 diabetes, due to cost, lack of reimbursement strategies, variability in healthcare infrastructure, and lack of trained health care providers (HCPs). The lack of regional guidelines tailored to the unique demographic, cultural, and health care needs of the Gulf population has resulted in low adoption and inconsistent use of CGM in clinical practice, leaving many patients without adequate advanced glucose monitoring options. This expert opinion statement evaluates the evidence for real-time CGM in the management of patients with type 2 diabetes and provides region-specific recommendations to guide HCPs in optimizing CGM use, improving patient outcomes, and addressing barriers to implementation in the Gulf region.